201. S-phase dependent cytogenetic toxicity of 5-fluorouracil in bone marrow cells of mice.
- Author
-
Choudhury RC, Misra S, Jagdale MB, and Palo AK
- Subjects
- Animals, Bone Marrow Cells cytology, Bone Marrow Cells pathology, Cell Line, Chromatids drug effects, Cricetinae, Cyclophosphamide pharmacology, Cyclophosphamide toxicity, Drosophila melanogaster genetics, Female, Fluorouracil pharmacology, Humans, Kinetics, Lymphocytes cytology, Male, Mice, Mice, Inbred ICR, Mice, Inbred Strains, Micronucleus Tests, Mitotic Index, Mutagenicity Tests, Salmonella typhimurium drug effects, Time Factors, Bone Marrow Cells drug effects, Chromosome Aberrations, Fluorouracil toxicity, Lymphocytes drug effects, Mutagens pharmacology, S Phase drug effects
- Abstract
The in vivo cytogenetic toxicity of three different doses (5,10 and 15 mg/kg) of 5-fluorouracil (5-FU) (in Fluracil) was assessed in bone marrow cells of mice. At 24 hrs post-treatment the induced chromosomal aberrations, mostly chromatid breaks and fragments, by all the three different concentrations of 5-FU were found statistically significant. However, mitotic index study at 24 hrs post-treatment indicated it as nonmitotoxic. At 30 hrs posttreatment, all the three doses of 5-FU induced a statistically significant number of micronuclei per thousand polychromatic erythrocytes. This indicated 5-FU as nonmitotoxic but highly clastogenic in bone marrow cells of mice.
- Published
- 2001